Accès à distance ? S'identifier sur le proxy UCLouvain
Safety and efficacy of Sofosbuvir/Velpatasvir for the treatment of chronic hepatitis C infection in adolescents and children aged 3 to 17 years old through 24 weeks post treatment
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Poster |
---|---|
Access type | Accès libre |
Publication date | 2020 |
Language | Anglais |
Conference | "The Liver Meeting Digital Experience - AASLD", WEBINAR (du 13/11/2020 au 16/11/2020) |
Journal information | "Journal of Hepatology. Supplement" - Vol. 72, no.931, p. 570A (2020) |
Peer reviewed | yes |
issn | 0169-5185 |
Publisher | Elsevier BV (Amsterdam) |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/PEDI - Pôle de Pédiatrie UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique |
Links |
Bibliographic reference | Sokal, Etienne ; et. al. Safety and efficacy of Sofosbuvir/Velpatasvir for the treatment of chronic hepatitis C infection in adolescents and children aged 3 to 17 years old through 24 weeks post treatment.The Liver Meeting Digital Experience - AASLD (WEBINAR, du 13/11/2020 au 16/11/2020). In: Journal of Hepatology. Supplement, Vol. 72, no.931, p. 570A (2020) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/243438 |